{"log_id": 5886527707723621545, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.000387, "average": 0.985802, "min": 0.945865}, "location": {"width": 175, "top": 177, "height": 28, "left": 235}, "words": "成人(18-64岁)"}, {"probability": {"variance": 3e-06, "average": 0.999081, "min": 0.993446}, "location": {"width": 413, "top": 222, "height": 42, "left": 230}, "words": "类风湿关节炎、强直性脊柱炎、银屑病"}, {"probability": {"variance": 0.00825, "average": 0.977206, "min": 0.544609}, "location": {"width": 484, "top": 272, "height": 46, "left": 276}, "words": "推荐剂量为25mg每周二次(间隔72-96小时)"}, {"probability": {"variance": 4.1e-05, "average": 0.996479, "min": 0.983132}, "location": {"width": 215, "top": 321, "height": 33, "left": 229}, "words": "老年患者(≥65岁)"}, {"probability": {"variance": 5e-06, "average": 0.998657, "min": 0.988665}, "location": {"width": 547, "top": 368, "height": 46, "left": 273}, "words": "无需进行剂量调整。用法用量与1864岁的成人相同"}, {"probability": {"variance": 0, "average": 0.999524, "min": 0.998714}, "location": {"width": 222, "top": 415, "height": 36, "left": 223}, "words": "肝肾功能损害的患者"}, {"probability": {"variance": 0, "average": 0.999574, "min": 0.997896}, "location": {"width": 195, "top": 465, "height": 31, "left": 271}, "words": "无需进行剂量调整"}, {"probability": {"variance": 1e-06, "average": 0.998752, "min": 0.997173}, "location": {"width": 100, "top": 512, "height": 29, "left": 220}, "words": "注射部位"}, {"probability": {"variance": 2e-06, "average": 0.999134, "min": 0.993959}, "location": {"width": 776, "top": 559, "height": 51, "left": 266}, "words": "本品的注射部位为大腿、腹部和上臂,注射方式为皮下注射。每次在不同"}, {"probability": {"variance": 0, "average": 0.999424, "min": 0.998925}, "location": {"width": 122, "top": 654, "height": 33, "left": 217}, "words": "或发硬部位"}, {"probability": {"variance": 0, "average": 0.999639, "min": 0.999361}, "location": {"width": 50, "top": 703, "height": 27, "left": 214}, "words": "处置"}, {"probability": {"variance": 0.022267, "average": 0.929596, "min": 0.408662}, "location": {"width": 423, "top": 747, "height": 47, "left": 258}, "words": "本品冻干粉在使用前必须置于2℃C-8°C"}, {"probability": {"variance": 0.000394, "average": 0.983465, "min": 0.949252}, "location": {"width": 334, "top": 596, "height": 318, "left": 586}, "words": "复印无效"}, {"probability": {"variance": 0.008793, "average": 0.975011, "min": 0.465674}, "location": {"width": 821, "top": 604, "height": 57, "left": 217}, "words": "部位注射,与前次注射部位至少相距3cm。禁止注射于皮肤囊嫩、瘀伤、发红"}, {"probability": {"variance": 0.000253, "average": 0.985604, "min": 0.9634}, "location": {"width": 149, "top": 669, "height": 113, "left": 916}, "words": "限公司"}, {"probability": {"variance": 2.9e-05, "average": 0.996563, "min": 0.985225}, "location": {"width": 260, "top": 760, "height": 42, "left": 777}, "words": "存,不可冷冻。在使用前"}, {"probability": {"variance": 1.4e-05, "average": 0.998013, "min": 0.98392}, "location": {"width": 401, "top": 796, "height": 41, "left": 209}, "words": "本品冻干粉需用1ml的注射用水复溶"}, {"probability": {"variance": 0.000904, "average": 0.989122, "min": 0.898963}, "location": {"width": 326, "top": 813, "height": 36, "left": 796}, "words": "即使用。如果不立即使"}, {"probability": {"variance": 0.020721, "average": 0.945899, "min": 0.466015}, "location": {"width": 867, "top": 835, "height": 88, "left": 206}, "words": "用,应将西林瓶中溶解后的本品注射液贮存20℃8℃C冰箱内,最长可保"}, {"probability": {"variance": 0.000507, "average": 0.991945, "min": 0.887215}, "location": {"width": 828, "top": 890, "height": 53, "left": 207}, "words": "小时。如未能在24小时内使用,应将溶液丢弃。在注射前,应使冷藏的溶液"}, {"probability": {"variance": 0, "average": 0.999546, "min": 0.999268}, "location": {"width": 75, "top": 941, "height": 28, "left": 204}, "words": "到室温"}, {"probability": {"variance": 0, "average": 0.999568, "min": 0.998625}, "location": {"width": 131, "top": 989, "height": 28, "left": 213}, "words": "【不良反应】"}, {"probability": {"variance": 0.004917, "average": 0.973014, "min": 0.733373}, "location": {"width": 326, "top": 1035, "height": 38, "left": 201}, "words": "安全信息汇总(据国外文献报道"}, {"probability": {"variance": 0.008229, "average": 0.978621, "min": 0.481162}, "location": {"width": 782, "top": 1073, "height": 54, "left": 248}, "words": "最常见的不皮应报告为注射部位反应(比如疼痛,肿胀,瘙痒,红斑和注"}, {"probability": {"variance": 0.000207, "average": 0.994356, "min": 0.933472}, "location": {"width": 796, "top": 1116, "height": 59, "left": 197}, "words": "射部位出血)感染(比如上呼吸道感染,支气管炎,膀胱感染和皮肤感染)"}, {"probability": {"variance": 0, "average": 0.999716, "min": 0.999215}, "location": {"width": 415, "top": 1169, "height": 40, "left": 196}, "words": "变态反应,自身抗体形成,瘙痒和发热"}, {"probability": {"variance": 6e-06, "average": 0.998823, "min": 0.98616}, "location": {"width": 778, "top": 1225, "height": 51, "left": 244}, "words": "本品也有严重不良反应的报道。肿瘤坏死因子抑制剂,比如本品,会影响免"}, {"probability": {"variance": 1e-06, "average": 0.999025, "min": 0.994271}, "location": {"width": 829, "top": 1272, "height": 51, "left": 192}, "words": "疫系统,它们的使用也许会影响患者自身对感染和肿瘤的抵抗能力。本品治疗后"}, {"probability": {"variance": 2.2e-05, "average": 0.997828, "min": 0.979188}, "location": {"width": 828, "top": 1320, "height": 51, "left": 193}, "words": "出现严重感染的患者小于1/100。安全性报告中也包含致命或威胁生命的感染和"}, {"probability": {"variance": 1.9e-05, "average": 0.998545, "min": 0.973681}, "location": {"width": 830, "top": 1368, "height": 51, "left": 189}, "words": "脓毒血症。使用本品的患者也有各种恶性肿瘤的报告,包括乳腺癌,皮肤癌和淋"}, {"probability": {"variance": 0, "average": 0.99934, "min": 0.998709}, "location": {"width": 53, "top": 1417, "height": 27, "left": 189}, "words": "巴瘤"}, {"probability": {"variance": 3e-06, "average": 0.998873, "min": 0.994207}, "location": {"width": 779, "top": 1463, "height": 51, "left": 236}, "words": "本品也有严重的血液系统、神经系统异常以及自身免疫反应的报告。这些包"}, {"probability": {"variance": 5e-06, "average": 0.998939, "min": 0.987591}, "location": {"width": 830, "top": 1511, "height": 50, "left": 185}, "words": "括罕见的全血细胞减少和十分罕见的再生障碍性贫血。使用本品的患者还有中枢"}], "language": 3}